Enrichment for chemoresistant ovarian cancer stem cells from human cell lines

Jennifer M. Cole, Stancy Joseph, Christopher G. Sudhahar, Karen Cowden Dahl

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) are defined as a subset of slow cycling and undifferentiated cells that divide asymmetrically to generate highly proliferative, invasive, and chemoresistant tumor cells. Therefore, CSCs are an attractive population of cells to target therapeutically. CSCs are predicted to contribute to a number of types of malignancies including those in the blood, brain, lung, gastrointestinal tract, prostate, and ovary. Isolating and enriching a tumor cell population for CSCs will enable researchers to study the properties, genetics, and therapeutic response of CSCs. We generated a protocol that reproducibly enriches for ovarian cancer CSCs from ovarian cancer cell lines (SKOV3 and OVCA429). Cell lines are treated with 20 µM cisplatin for 3 days. Surviving cells are isolated and cultured in a serum-free stem cell media containing cytokines and growth factors. We demonstrate an enrichment of these purified CSCs by analyzing the isolated cells for known stem cell markers Oct4, Nanog, and Prom1 (CD133) and cell surface expression of CD177 and CD133. The CSCs exhibit increased chemoresistance. This method for isolation of CSCs is a useful tool for studying the role of CSCs in chemoresistance and tumor relapse.

Original languageEnglish
Article numbere51891
JournalJournal of visualized experiments : JoVE
Issue number91
DOIs
StatePublished - Sep 10 2014

Fingerprint

Neoplastic Stem Cells
Stem cells
Ovarian Neoplasms
Cells
Cell Line
Tumors
Neoplasms
Stem Cells
Cisplatin
Population
Gastrointestinal Tract
Prostate
Ovary
Cultured Cells
Intercellular Signaling Peptides and Proteins
Research Personnel
Brain
Cytokines
Blood
Recurrence

Keywords

  • Cancer progression
  • Cancer stem cells
  • Chemoresistance
  • Cisplatin
  • Issue 91
  • Medicine
  • ovarian cancer
  • Stem cell markers

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Medicine(all)

Cite this

Enrichment for chemoresistant ovarian cancer stem cells from human cell lines. / Cole, Jennifer M.; Joseph, Stancy; Sudhahar, Christopher G.; Cowden Dahl, Karen.

In: Journal of visualized experiments : JoVE, No. 91, e51891, 10.09.2014.

Research output: Contribution to journalArticle

Cole, Jennifer M. ; Joseph, Stancy ; Sudhahar, Christopher G. ; Cowden Dahl, Karen. / Enrichment for chemoresistant ovarian cancer stem cells from human cell lines. In: Journal of visualized experiments : JoVE. 2014 ; No. 91.
@article{9254c32840b143c59cdf383c56b1fa34,
title = "Enrichment for chemoresistant ovarian cancer stem cells from human cell lines",
abstract = "Cancer stem cells (CSCs) are defined as a subset of slow cycling and undifferentiated cells that divide asymmetrically to generate highly proliferative, invasive, and chemoresistant tumor cells. Therefore, CSCs are an attractive population of cells to target therapeutically. CSCs are predicted to contribute to a number of types of malignancies including those in the blood, brain, lung, gastrointestinal tract, prostate, and ovary. Isolating and enriching a tumor cell population for CSCs will enable researchers to study the properties, genetics, and therapeutic response of CSCs. We generated a protocol that reproducibly enriches for ovarian cancer CSCs from ovarian cancer cell lines (SKOV3 and OVCA429). Cell lines are treated with 20 µM cisplatin for 3 days. Surviving cells are isolated and cultured in a serum-free stem cell media containing cytokines and growth factors. We demonstrate an enrichment of these purified CSCs by analyzing the isolated cells for known stem cell markers Oct4, Nanog, and Prom1 (CD133) and cell surface expression of CD177 and CD133. The CSCs exhibit increased chemoresistance. This method for isolation of CSCs is a useful tool for studying the role of CSCs in chemoresistance and tumor relapse.",
keywords = "Cancer progression, Cancer stem cells, Chemoresistance, Cisplatin, Issue 91, Medicine, ovarian cancer, Stem cell markers",
author = "Cole, {Jennifer M.} and Stancy Joseph and Sudhahar, {Christopher G.} and {Cowden Dahl}, Karen",
year = "2014",
month = "9",
day = "10",
doi = "10.3791/51891",
language = "English",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "91",

}

TY - JOUR

T1 - Enrichment for chemoresistant ovarian cancer stem cells from human cell lines

AU - Cole, Jennifer M.

AU - Joseph, Stancy

AU - Sudhahar, Christopher G.

AU - Cowden Dahl, Karen

PY - 2014/9/10

Y1 - 2014/9/10

N2 - Cancer stem cells (CSCs) are defined as a subset of slow cycling and undifferentiated cells that divide asymmetrically to generate highly proliferative, invasive, and chemoresistant tumor cells. Therefore, CSCs are an attractive population of cells to target therapeutically. CSCs are predicted to contribute to a number of types of malignancies including those in the blood, brain, lung, gastrointestinal tract, prostate, and ovary. Isolating and enriching a tumor cell population for CSCs will enable researchers to study the properties, genetics, and therapeutic response of CSCs. We generated a protocol that reproducibly enriches for ovarian cancer CSCs from ovarian cancer cell lines (SKOV3 and OVCA429). Cell lines are treated with 20 µM cisplatin for 3 days. Surviving cells are isolated and cultured in a serum-free stem cell media containing cytokines and growth factors. We demonstrate an enrichment of these purified CSCs by analyzing the isolated cells for known stem cell markers Oct4, Nanog, and Prom1 (CD133) and cell surface expression of CD177 and CD133. The CSCs exhibit increased chemoresistance. This method for isolation of CSCs is a useful tool for studying the role of CSCs in chemoresistance and tumor relapse.

AB - Cancer stem cells (CSCs) are defined as a subset of slow cycling and undifferentiated cells that divide asymmetrically to generate highly proliferative, invasive, and chemoresistant tumor cells. Therefore, CSCs are an attractive population of cells to target therapeutically. CSCs are predicted to contribute to a number of types of malignancies including those in the blood, brain, lung, gastrointestinal tract, prostate, and ovary. Isolating and enriching a tumor cell population for CSCs will enable researchers to study the properties, genetics, and therapeutic response of CSCs. We generated a protocol that reproducibly enriches for ovarian cancer CSCs from ovarian cancer cell lines (SKOV3 and OVCA429). Cell lines are treated with 20 µM cisplatin for 3 days. Surviving cells are isolated and cultured in a serum-free stem cell media containing cytokines and growth factors. We demonstrate an enrichment of these purified CSCs by analyzing the isolated cells for known stem cell markers Oct4, Nanog, and Prom1 (CD133) and cell surface expression of CD177 and CD133. The CSCs exhibit increased chemoresistance. This method for isolation of CSCs is a useful tool for studying the role of CSCs in chemoresistance and tumor relapse.

KW - Cancer progression

KW - Cancer stem cells

KW - Chemoresistance

KW - Cisplatin

KW - Issue 91

KW - Medicine

KW - ovarian cancer

KW - Stem cell markers

UR - http://www.scopus.com/inward/record.url?scp=84908337673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908337673&partnerID=8YFLogxK

U2 - 10.3791/51891

DO - 10.3791/51891

M3 - Article

C2 - 25285606

AN - SCOPUS:84908337673

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 91

M1 - e51891

ER -